• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

MicuRx - Articles and news items

phase-iii-mrsa

MicuRx’S Phase III MRSA antibiotic trial to support Chinese NDA filing

Industry news / 20 October 2016 / Niamh Louise Marriott, Digital Content Producer

The recent $55M Series C financing will allow MicuRx to complete this Phase 3 study, and at a vital time with antibiotic resistance at an all time high…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +